Stay updated on FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial
Sign up to get notified when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.

Latest updates to the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a note about the 2018 U.S. NIH Grant/Contract and updated the revision to v3.6.6, with the previous revision v3.6.5 removed.SummaryDifference0.1%

- Check16 days agoChange DetectedOutage banners at the top of the page have been removed. The page now presents the study details without the prior global service disruption notice.SummaryDifference0.1%

- Check23 days agoChange DetectedSitewide outage warning and a note about intermittent delays to NCBI services were added, indicating a temporary service disruption. The previous revision tag v3.6.4 was removed and updated to v3.6.5.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded metadata about the study's last known status, sponsor, and last verification date, and removed the note indicating no longer recruiting participants, altering how the page presents current enrollment information.SummaryDifference0.3%

- Check44 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a platform version update behind the page. This change represents a backend software bump and does not alter study content or visible information.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page's revision label was updated from v3.6.1 to v3.6.3, indicating a newer version of the study details page.SummaryDifference0.0%

Stay in the know with updates to FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.